Economics of chronic diseases protocol: Cost-effectiveness modelling and the future burden of non-communicable disease in Europe

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Divajeva, Diana ^a   Marsh, Tim ^a   Logstrup, Susanne ^b   Kestens, Marleen ^b   Vemer, Pepijn ^c,d   Kriaucioniene, Vilma ^e   Peresson, Sophie ^f   O'Kelly, Sophie ^g   Rito, Ana ^h   Webber, Laura ^a  

^a UK Health Forum   (United Kingdom)

^b European Heart Network (EHN)   (Belgium)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^f International Diabetes Federation (IDF)   (Belgium)

^g European Society of Cardiology   (France)

^h NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Chronic disease; Cost effectiveness; Europe; Future burden; Modelling

Indexed keywords

CHRONIC DISEASE; CORONARY DISEASE; COST BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; ECONOMICS; EUROPE; FORECASTING; HEALTH CARE COST; HUMAN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

CHRONIC DISEASE; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; EUROPE; FORECASTING; HEALTH CARE COSTS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84902146213     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-456     Document Type: Article

References (13)

1. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, et al. Lancet 2012 380 2224 2260 10.1016/S0140-6736(12)61766-8 23245609
2. Major and Cronic Diseases. http://ec.europa.eu/health/archive/ph-threats/ non-com/docs/mcd-report-en.pdf
3. The Global Economic Burden of Noncommunicable Diseases. Bloom D, Cafiero E, 2012 http://apps.who.int/medicinedocs/documents/s18806en/s18806en.pdf
4. World Health Organization, Noncommunicable Diseases Country Profiles 2011 Geneva: WHO Press 2011
5. World Health Organization, Global Status Report on Noncommunicable Diseases 2010 Geneva: WHO Press 2011
6. Tackling Chronic Disease in Europe. Strategies, Interventions and Challenges. Busse R, Blümel M, Scheller-Kreinsen D, Zentner A, 2010 http://www.euro.who.int/-data/assets/pdf-file/0008/96632/E93736.pdf
7. Regional Committee for Europe, Health 2020 Policy Framework and Strategy 2012 10 13
8. UCL Institute of Health Equity, Review of Social Determinants and the Health Divide in the WHO European Region: Final Report 2013
9. Budget crises, health, and social welfare programmes. Stuckler D, Basu S, McKee M, BMJ 2010 340 3311 10.1136/bmj.c3311 20576709
10. Economic Implications of Socio-economic Inequalities in Health in the European Union. Mackenbach J, Meerding W, Kunst A, 2007 http://ec.europa.eu/ health/ph-determinants/socio-economics/documents/socioeco-inequalities-en.pdf
11. European Commission Call for Proposals. 2013 http://ec.europa.eu/eahc/ documents/health/calls/2013/2013-GUIDE-Projects.pdf
12. Government Office for Science, Tackling Obesities: Future Choices. Project Report 2 2007
13. Health and economic burden of the projected obesity trends in the USA and the UK. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M, Lancet 2011 378 815 825 10.1016/S0140-6736(11)60814-3 21872750